Long non-coding RNA DHRS4 antisense RNA 1 inhibits ectopic endometrial cell proliferation, migration, and invasion in endometriosis by regulating microRNA-139-5p expression

References

• Vercellini P, Viganò P, Somigliana E, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–275.
   PubMed Web of Science ®Google Scholar
• Binda MM, Donnez J, Dolmans MM. Targeting mast cells: a new way to treat endometriosis. Expert Opin Ther Targets. 2017;21(1):67–75.
   PubMed Web of Science ®Google Scholar
• Garcia-Fernandez J, García-Velasco JA. Endometriosis and reproduction: what we have learned. Yale J Biol Med. 2020;93(4):571–577.
   PubMed Web of Science ®Google Scholar
• Rafique S, Decherney AH. Medical management of endometriosis. Clin Obstet Gynecol. 2017;60(3):485–496.
   PubMed Web of Science ®Google Scholar
• Liu HW, Zhang W, Wang LL, et al. GLI1 is increased in ovarian endometriosis and regulates migration, invasion and proliferation of human endometrial stromal cells in endometriosis. Ann Transl Med. 2019;7(22):663.
   PubMed Web of Science ®Google Scholar
• Nezhat CR, Stevens A, Balassiano E, et al. Robotic-assisted laparoscopy vs conventional laparoscopy for the treatment of advanced stage endometriosis. J Minim Invasive Gynecol. 2015;22(1):40–44.
   PubMed Web of Science ®Google Scholar
• Kiesel L, Sourouni M. Diagnosis of endometriosis in the 21st century. Climacteric. 2019;22(3):296–302.
   PubMed Web of Science ®Google Scholar
• Rosa VLL, de Franciscis P, Barra F, et al. Sexuality in women with endometriosis: a critical narrative review. Minerva Med. 2020;111(1):79–89.
   PubMed Web of Science ®Google Scholar
• Rizk B, Fischer AS, Lotfy HA, et al. Recurrence of endometriosis after hysterectomy. Facts Views Vis Obgyn. 2014;6(4):219–227.
   PubMedGoogle Scholar
• Králíčková M, Losan P, Vetvicka V. Endometriosis and cancer. Womens Health (Lond). 2014;10(6):591–597.
   PubMedGoogle Scholar
• Wang J, Yao X, Wu DL, et al. Kallikrein-related peptidase 4 promotes migration and invasion of endometrial stromal cells in endometriosis by inducing epithelial-mesenchymal transition. J Biol Regul Homeost Agents. 2020;34(1):93–100.
   PubMed Web of Science ®Google Scholar
• Lu Q, Huang Y, Wu J, et al. T-cadherin inhibits invasion and migration of endometrial stromal cells in endometriosis. Hum Reprod. 2020;35(1):145–156.
   PubMed Web of Science ®Google Scholar
• Yan W, Hu H, Tang B. Progress in understanding the relationship between long noncoding RNA and endometriosis. Eur J Obstet Gynecol Reprod Biol X. 2019;5:100067.
   PubMedGoogle Scholar
• Ghafouri-Fard S, Shoorei H, Taheri M. Role of non-coding rnas in the pathogenesis of endometriosis. Front Oncol. 2020;10:1370.
   PubMed Web of Science ®Google Scholar
• Mai H, Xu H, Lin HS, et al. LINC01541 functions as a ceRNA to modulate the Wnt/β-catenin pathway by decoying miR-506-5p in endometriosis. Reprod Sci. 2021;28(3):665–674.
   PubMed Web of Science ®Google Scholar
• Feng Y, Tan BZ. LncRNA MALAT1 inhibits apoptosis of endometrial stromal cells through miR-126-5p-CREB1 axis by activating PI3K-AKT pathway. Mol Cell Biochem. 2020;475(1–2):185–194.
   PubMedGoogle Scholar
• Liu XM, Wei JL, Ma ZL, et al. Rapamycin- and starvation-induced autophagy are associated with miRNA dysregulation in A549 cells. Acta Biochim Biophys Sin (Shanghai). 2019;51(4):393–401.
   PubMed Web of Science ®Google Scholar
• Olejniczak M, Kotowska-Zimmer A, Krzyzosiak W. Stress-induced changes in miRNA biogenesis and functioning. Cell Mol Life Sci. 2018;75(2):177–191.
   PubMed Web of Science ®Google Scholar
• Chipman LB. Pasquinelli AE. miRNA targeting: growing beyond the seed. Trends Genet. 2019;35(3):215–222.
   PubMed Web of Science ®Google Scholar
• Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 2015;5(10):1122–1143.
   PubMed Web of Science ®Google Scholar
• Benz F, Roy S, Trautwein C, et al. Circulating microRNAs as biomarkers for sepsis. Int J Mol Sci. 2016;17(1):78.
   PubMed Web of Science ®Google Scholar
• Rekker K, Tasa T, Saare M, et al. Differentially-expressed miRNAs in ectopic stromal cells contribute to eEndometriosis development: the plausible role of miR-139-5p and miR-375. Int J Mol Sci. 2018;19(12):3789.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li K, Zou X, et al. LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis. Bioengineered. 2021;12(2):10862–10877.
   PubMed Web of Science ®Google Scholar
• Yan F, Zhao W, Xu XY, et al. LncRNA DHRS4-AS1 inhibits the stemness of NSCLC cells by sponging miR-224-3p and upregulating TP53 and TET1. Front Cell Dev Biol. 2020;8:585251.
   PubMed Web of Science ®Google Scholar
• Wang CL, Wang G, Zhang ZJ, et al. The downregulated long non-coding RNA DHRS4-AS1 is protumoral and associated with the prognosis of clear cell renal cell carcinoma. Onco Targets Ther. 2018;11:5631–5646.
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20): 2191–2194.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang S, Tang L, et al. Downregulated circular RNA hsa_circ_0067301 regulates epithelial-mesenchymal transition in endometriosis via the miR-141/Notch signaling pathway. Biochem Biophys Res Commun. 2019;514(1):71–77.
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang Z, Xiong W, et al. Hypoxia-inducible factor-1alpha promotes endometrial stromal cells migration and invasion by upregulating autophagy in endometriosis. Reproduction. 2017;153:809–820.
   PubMed Web of Science ®Google Scholar
• Wang HX, Ni CX, Xiao W, et al. Role of lncRNA FTX in invasion, metastasis, and epithelial-mesenchymal transition of endometrial stromal cells caused by endometriosis by regulating the PI3K/Akt signaling pathway. Ann Transl Med. 2020;8(22):1504.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Hnasko TS, Hnasko RM. The Western Blot. Methods Mol Biol. 2015;1318:87–96.
   PubMedGoogle Scholar
• Kumar P, Nagarajan A, Uchil PD. Analysis of Cell Viability by the MTT Assay. Cold Spring Harb Protoc. 2018;2018(6):469–471.
   Google Scholar
• Li G, Wu X, Sun P, et al. Dithiolation indolizine exerts viability suppression effects on A549 cells via triggering intrinsic apoptotic pathways and inducing G2/M phase arrest. Biomed Pharmacother. 2021;133:110961.
   PubMed Web of Science ®Google Scholar
• Justus CR, Leffler N, Ruiz-Echevarria M, et al. In vitro cell migration and invasion assays. J Vis Exp. 2014;88:51046.
   Google Scholar
• Clément T, Salone V, Rederstorff M. Dual luciferase gene reporter assays to study miRNA function. Methods Mol Biol. 2015;1296:187–198.
   PubMedGoogle Scholar
• Montenegro ML, Bonocher CM, Meola J, et al. Effect of physical exercise on endometriosis experimentally induced in rats. Reprod Sci. 2019;26(6):785–793.
   PubMed Web of Science ®Google Scholar
• Ladanyi C, Boyd S, Sticco P, et al. Postmenopausal endometriosis, where are we now? Curr Opin Obstet Gynecol. 2019;31(4):267–278.
   PubMed Web of Science ®Google Scholar
• Luddi A, Marrocco C, Governini L, et al. Expression of matrix metalloproteinases and their inhibitors in endometrium: high levels in endometriotic lesions. Int J Mol Sci. 2020;21(8):2840.
   PubMed Web of Science ®Google Scholar
• Zakhari A, Edwards D, Ryu M, et al. Dienogest and the risk of endometriosis recurrence following surgery: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2020;27(7):1503–1510.
   PubMed Web of Science ®Google Scholar
• Hombach S, Kretz M. Non-coding RNAs: classification, biology and functioning. Adv Exp Med Biol. 2016;937:3–17.
   PubMed Web of Science ®Google Scholar
• Wei H, Huang LW, Wei FH, et al. Up-regulation of miR-139-5p protects diabetic mice from liver tissue damage and oxidative stress through inhibiting Notch signaling pathway. Acta Biochim Biophys Sin (Shanghai). 2020;52(4):9390–9400.
   Web of Science ®Google Scholar
• Zhang ZY, Shen LF, Yan YY. MiR-139-5p alleviates neural cell apoptosis induced by spinal cord injury through targeting TRAF3. Acta Biochim Pol. 2020;67(3):359–365.
   PubMed Web of Science ®Google Scholar
• Liang JQ, Liao HR, Xu CX, et al. Serum exosome-derived miR-139-5p as a potential biomarker for major depressive disorder. Neuropsychiatr Dis Treat. 2020;16:2689–2693.
   PubMed Web of Science ®Google Scholar
• Huang J, Zheng LL, Kong HF, et al. miR-139-5p promotes the proliferation and invasion of trophoblast cells by targeting sFlt-1 in preeclampsia. Placenta. 2020;92:37–42.
   PubMed Web of Science ®Google Scholar
• Hua SN, Lei L, Deng L, et al. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Oncogene. 2018;37(12):1624–1636.
   PubMed Web of Science ®Google Scholar
• Li JF, He X, Wu XT, et al. Gong YC. miR-139-5p inhibits lung adenocarcinoma cell proliferation, migration, and invasion by targeting MAD2L1. Comput Math Methods Med. 2020;2020:953598.
   Web of Science ®Google Scholar
• Shi YK, Guo YH. MiR-139-5p suppresses osteosarcoma cell growth and invasion through regulating DNMT1. Biochem Biophys Res Commun. 2018;503(2):459–466.
   PubMed Web of Science ®Google Scholar
• Li JL, Li QB, Lin L, et al. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT). BMC Neurol. 2018;18(1):133.
   PubMed Web of Science ®Google Scholar
• Liu JH, Li CY, Jiang Y, et al. Tumor-suppressor role of miR-139-5p in endometrial cancer. Cancer Cell Int. 2018;18(1):51.
   PubMedGoogle Scholar
• Yu C, Li L, Xie F. LncRNA TUG1 sponges miR-204-5p to promote osteoblast differentiation through upregulating Runx2 in aortic valve calcification. Cardiovasc Res. 2018;114(1):168–179.
   PubMed Web of Science ®Google Scholar
• Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016;1402:271–286.
   PubMedGoogle Scholar
• Shen X, Sun X, Sun B, et al. ARRDC3 suppresses colorectal cancer progression through destabilizing the oncoprotein YAP. FEBS Lett. 2018;592(4):599–609.
   PubMed Web of Science ®Google Scholar
• Lei D, Deng N, Wang S, et al. Upregulated ARRDC3 limits trophoblast cell invasion and tube formation and is associated with preeclampsia. Placenta. 2020;89:10–19.
   PubMed Web of Science ®Google Scholar